Leaflet ATGAM 50mg / ml concentrate for solution for infusion

Indicated for: immunosuppression

Route of administration: infusion

Substance: anti-lymphocyte immunoglobulin (horse) (immunoglobulin)

ATC: L04AA03 (Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Horse anti-lymphocyte immunoglobulin is used for the prevention and treatment of acute rejection in organ transplantation. It works by suppressing the body's immune response, reducing T-lymphocyte activity.

The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.

Side effects may include fever, chills, skin rashes, or injection site reactions. In rare cases, severe allergic reactions or opportunistic infections may occur.

Horse anti-lymphocyte immunoglobulin is not recommended for patients with hypersensitivity to animal-derived proteins or active severe infections.

General data about ATGAM 50mg / ml

  • Substance: anti-lymphocyte immunoglobulin (horse)
  • Date of latest medicines list: 01-06-2026
  • Product code: W68563001
  • Concentration: 50mg / ml
  • Pharmaceutical form: concentrate for solution for infusion
  • Quantity: 5
  • Product type: Original
  • Price: 14499.46 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: PFIZER SERVICE COMPANY BV - BELGIA
  • Holder: PFIZER EUROPE MA EEIG - BELGIA
  • Number: 14292/2022/01
  • Shelf life: 2 years-after packaging for sale; after reconstitution-24h

Compensation lists for ATGAM 50mg / ml Pfizer

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

14499.46 RON

14499.46 RON

0.00 RON